SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bayer CropScience Ltd. (Merged) (AGREVOIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530415 NSE: AGREVOIND Pesticides & Agrochemicals | Small Cap | Bayer CropSci.(Merg) Share Price

BSE Share Price
Not Listed

Bayer CropScience Ltd. (Merged) (AGREVOIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530415 NSE: AGREVOIND Pesticides & Agrochemicals | Small Cap | Bayer CropSci.(Merg) Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹436 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹207.3
TTM Sales
₹3,245 Cr.
Book Value per Share
₹102.8
P/E Ratio
1.51
Industry PE
31.4
Price to Book (P/B)
3.04
Price to Sales (P/S)
0.13
EV/EBITDA
-0.10
Dividend Yield
INF%
Profitability Efficiency
Return on Equity (ROE)
15.76%
Return on Capital Employed (ROCE)
24.26%
Return on Assets (ROA)
12.09%
Operating Profit Margin
13.1%
Net Profit Margin
8.92%
Gross Profit Margin
14.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
19.08%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
16.5%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-75.08%
Asset Quality
Promoter Holding
67.35%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹130 Cr.
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
₹77.50 / 939.75

Bayer CropScience . (Merged) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % 0%0%0%0%0%0%41.3%26.2%115%24.3%-

Growth Parameters

Sales 0000002,1372,2722,7253,2453,245
Sales YoY Gr.-NANANANANANA6.3%19.9%19.1%-
Adj EPS 00000033.645.186.780.2207.3
YoY Gr.-NANANANANANA34%92.4%-7.5%-
BVPS (₹) 000000170.4200.7489475.8102.8
Adj Net
Profit
0000001331783422940
Cash Flow from Ops. 000000122107138282-
Debt/CF from Ops. 0000000.9000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA14.9%19.1%
Adj EPS NANA33.6%-7.5%
BVPSNANA40.8%-2.7%
Share Price - - - -

Key Financial Parameters

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
00000033.424.325.11671.7
Op. Profit
Mgn %
00000010.411.213.413.20
Net Profit
Mgn %
0000006.27.812.69.10
Debt to
Equity
0000000.2000-
Working Cap
Days
000000861521431360
Cash Conv.
Cycle
000000416364620

Profit And Loss

(All Figures are in Crores.)
PARTICULARSDec'01Dec'02Mar'11Mar'12Mar'13Mar'14
Sales432.56308.762,137.302,272.302,725.303,245.20
Operating Expenses + 382.45281.821,914.202,019.602,365.402,825.90
Manufacturing Costs9.229.1435.8038.3053.7059.90
Material Costs267.07177.541,375.701,460.601,745.402,095.60
Employee Cost 12.6816.19150.10147.50181204
Other Costs 93.4778.95352.60373.20385.30466.40
Operating Profit 50.1226.94223.10252.70359.90419.30
Operating Profit Margin (%) 11.6%8.7%10.4%11.1%13.2%12.9%
Other Income + 4.689.1620.5045.3068.9090.90
Exceptional Items 14.860.73-3.80-57.901,174.700
Interest 14.769.248.301.703.704.80
Depreciation 5.595.8132.703436.6064.60
Profit Before Tax 49.3121.78198.80204.401,563.20440.80
Tax 18.397.2567.2065.40401.50151.30
Profit After Tax 30.9214.53131.601391,161.70289.50
PAT Margin (%) 7.2%4.7%6.2%6.1%42.6%8.9%
Adjusted EPS (₹)22.110.433.335.2294.179.1
Dividend Payout Ratio (%)18.10%19.20%12%11.90%1.70%6.90%

Valuation of Bayer CropSci.(Merg) - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSDec'01Dec'02Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund + 111.99123.37673792.701,931.301,742.30
Share Capital 13.9713.9739.5039.5039.5036.60
Reserves 98.03109.40633.50753.201,891.801,705.70
Debt +103.3398.56108.50000
Long Term Debt103.3398.560000
Short Term Debt00108.50000
Minority Interest000000
Trade Payables63.7144.27295260.50197.20292.10
Others Liabilities 21.2920.18477.20777.10286.50338.60
Total Liabilities 300.33286.391,553.701,830.302,4152,373

Fixed Assets

Net Fixed Assets +47.2745.71347.60247.80218.60227.80
Gross Block85.8689.35537.70455.70405469.70
Accumulated Depreciation38.5943.65190.10207.90186.40241.90
CWIP 04.786.108.80127.10216.80
Investments 0.400.453.603.603.703.70
Inventories45.9096.17437.40499.50500549.50
Trade Receivables168.5693.83281.40256.20322.40409.90
Cash Equivalents 14.9215.80363429.90974.10486.20
Others Assets 23.2829.65114.60384.50269.10479.10
Total Assets 300.33286.391,553.701,830.302,4152,373

Cash Flow

(All Figures are in Crores.)
PARTICULARSDec'01Dec'02Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity + 71.4026.30122.30106.70138.30281.50
PBT 34.4421.04198.80204.401,563.20440.80
Adjustment 25.7310.884340-1,182.60-2.20
Changes in Working Capital 12.89.83-64-63.7-119.73.3
Tax Paid -15.94-16.18-55.50-74-122.60-160.40
Cash Flow From Investing Activity + -3.82-4.58195.1088.50427-289.70
Capex -4.01-5.18-67.30-49.60645.60-159.20
Net Investments -00.0400-0.100
Others 0.190.55262.40138.10-218.50-130.50
Cash Flow From Financing Activity + -53.70-20.83-32.40-128.50-21.30-479.60
Net Proceeds from Shares 000000
Net Proceeds from Borrowing 01.250000
Interest Paid -15.44-10.49-8.50-1.70-2-1.50
Dividend Paid -1.67-5.58-15.80-15.70-19.30-23.10
Others -36.60-6.02-8.10-111.100-455
Net Cash Flow 13.880.8828566.70544-487.80

Financial Ratio

PARTICULARSDec'01Dec'02Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)27.6112.3533.0518.9785.2915.76
ROCE (%)29.7514.1941.2826.18115.0424.26
Asset Turnover Ratio1.551.132.421.41.341.42
PAT to CFO Conversion(x)2.311.810.930.770.120.97
Working Capital Days
Receivable Days131.90143.9030.8041.5037.2039.30
Inventory Days35.9077.9043.8072.4064.3056.40
Payable Days85.10107.9044.8069.4047.9042.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bayer CropScience Ltd. (Merged) FAQs

The current trading price of Bayer CropSci.(Merg) on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Bayer CropSci.(Merg) stood at ₹436.4 Cr

The latest P/E ratio of Bayer CropSci.(Merg) as of 31-Dec-1969 is 1.51.

The latest P/B ratio of Bayer CropSci.(Merg) as of 31-Dec-1969 is 3.04.

The 52-week high of Bayer CropSci.(Merg) is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bayer CropSci.(Merg) is ₹3,245 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Bayer CropScience Ltd. (Merged)

No data to display
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: